CAMP and atherosclerosis: Among AMPs, the role of the cathelicidins (human LL-37 and mouse CRAMP) has been particularly documented in autoimmune diseases such as atherosclerosis, small-vessel vasculitis, systemic lupus erythematous, and psoriasis [22,23,24,25].